Table 3.
Frequently distribution of patients based on metastasis site, lymph nodes, and survival in the past 5 years
| Metastasis site | Survived in the past 5 years, n (%) | Not survived in the past 5 years, n (%) | Total, n (%) |
|---|---|---|---|
| Lymph nodes | 0 | 2 (6/3) | 2 (1/2) |
| Digestive system | 0 | 1 (8/1) | 1 (1) |
| Lung | 1 (5/2) | 3 (6/3) | 4 (2/4) |
| Esophagus and pharynx | 0 | 2 (6/3) | 2 (1/2) |
| Pharynx | 0 | 2 (6/3) | 2 (2/1) |
| Esophagus | 0 | 4 (1/7) | 4 (2/4) |
| Jaw bone | 2 (5) | 2 (6/3) | 4 (2/4) |
| Bone | 0 | 7 (5/12) | 7 (3/7) |
| Pharynx, larynx, and esophagus | 0 | 1 (8/1) | 1 (1) |
| Pharynx | 0 | 2 (6/3) | 2 (½) |
| Pharynx and neck skin | 0 | 1 (8/1) | 1 (1) |
| Stomach | 0 | 1 (8/1) | 1 (1) |
| Vessels and neck skin | 0 | 1 (8/1) | 1 (1) |
| Esophagus and lung | 0 | 1 (8/1) | 1 (1) |
| Stomach and forehead skin | 1 (5/2) | 0 | 1 (1) |
| Brain | 0 | 1 (8/1) | 1 (1) |
| Jawbone, skull, and temporal arteries | 0 | 1 (8/1) | 1 (1) |
| All site | 4 (11.11) | 32 (88.88) | 36 (100) |